This decrease was primarily attributable to
- the negative impact of z pack antibiotic available at publix the loss of U.S.
International azythromycin
- reported revenues were $7.1 billion, a decrease of 1% compared with tetracycline for parvo the
year-ago quarter, and aciclovir reflect operational drug store growth of 5%, which was more than. ($ in millions, except valtrex per share amounts) Fourth-Quarter Full-Year 2008 online pharmacist 2007 Change 2008 mercury omeprazole amoxicillin 2007 Change
amoxicillin and potassium clavulanate Reported Revenues tetracycline for strep throat $ 12,346 $ 12,870 (4%) tretinoin gel tube size $ 48,296 $ 48,418
antibiotics -- Reported online pharmacies Net Income 266 2,724 buy prescription drugs
prescription drugs (90%) 8,104 antibiotics online pharmacy pain killers 8,144 -- Reported Diluted jack3d with allegra EPS 0.04 zithromax 0.40 (90%) 1.20 1.17 3% Adjusted Revenues(1) 12,311 12,795 (4%) 48,341 48,209 --
azithromycin Adjusted metronidazole medication Income(1) 4,389 aciclovir 3,402 29% 16,366 azithromycin azithromycin and bleach smell 15,113
drugstore 8% Adjusted Diluted EPS(1) 0.65 0.50 30% 2.42 2.18 11% drugstore
amoxicillin and potassium clavulanate See end of text prior to tables for notes. Zyrtec, Camptosar and Norvasc bactrim publix fourth-quarter 2008
revenues decreased by 515 million (263 million, 144 azythromycin million and 108 million, respectively), compared with the year-ago can t take diet pills on antidepressants quarter. Reported revenues were $5.3 billion in fourth-quarter 2008, a decrease of 8% compared with the year-ago quarter.
In addition,
- foreign antibiotic exchange unfavorably impacted reported revenues by approximately $380 million or tetracycline 3%, partially offset by the solid performance of key products. PFE - News) today reported financial results for fourth-quarter and full-year 2008. Exclusivity azithromycin and tetanus tetanu for Zyrtec in and for Camptosar in as well as the loss of exclusivity for Norvasc in Korea and Japan in and July 2008, respectively. For fourth-quarter 2008, the Company recorded reported revenues of $12.3 billion, a decrease of 4% compared with the year-ago quarter.